These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2857632)
1. Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease. Karbach U; Ewe K; Dehos H Dig Dis Sci; 1985 Mar; 30(3):229-35. PubMed ID: 2857632 [TBL] [Abstract][Full Text] [Related]
2. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents. Griffiths AM; Drobnies A; Soldin SJ; Hamilton JR J Pediatr Gastroenterol Nutr; 1986; 5(6):907-11. PubMed ID: 3491890 [TBL] [Abstract][Full Text] [Related]
3. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Karbach U; Ewe K; Bodenstein H Gut; 1983 Aug; 24(8):718-23. PubMed ID: 6603392 [TBL] [Abstract][Full Text] [Related]
4. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance. Karbach U; Singe CC; Ewe K Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475 [TBL] [Abstract][Full Text] [Related]
5. Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance. Karbach U; Ewe K Z Gastroenterol; 1989 Jul; 27(7):362-5. PubMed ID: 2475983 [TBL] [Abstract][Full Text] [Related]
6. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin? Hundegger K; Stufler M; Karbach U Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675 [TBL] [Abstract][Full Text] [Related]
7. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease. Thomas DW; Sinatra FR; Merritt RJ J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798 [TBL] [Abstract][Full Text] [Related]
9. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110 [TBL] [Abstract][Full Text] [Related]
10. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy]. Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740 [TBL] [Abstract][Full Text] [Related]
11. [Usefulness of intestinal clearance of alpha-1-antitrypsin in the diagnosis of protein-losing syndromes]. Sategna-Guidetti C; Rutigliano A Recenti Prog Med; 1983 May; 74(5):543-52. PubMed ID: 6604301 [No Abstract] [Full Text] [Related]
12. Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin. Weisdorf SA; Salati LM; Longsdorf JA; Ramsay NK; Sharp HL Gastroenterology; 1983 Nov; 85(5):1076-81. PubMed ID: 6352387 [TBL] [Abstract][Full Text] [Related]
13. [Alpha 1-antitrypsin as an endogenous marker of protein-losing enteropathies]. Kulesza E; Lisowska B; Tomaszewski L; Dobrowolski W; Socha J Pol Tyg Lek; 1992 Jan 20-27; 47(3-4):98-101. PubMed ID: 1437795 [TBL] [Abstract][Full Text] [Related]
14. Alpha 1-antitrypsin clearance as an aid in the management of patients with celiac disease. Bai JC; Sambuelli A; Niveloni S; Sugai E; Mazure R; Kogan Z; Pedreira S; Boerr L Am J Gastroenterol; 1991 Aug; 86(8):986-91. PubMed ID: 1858765 [TBL] [Abstract][Full Text] [Related]